Andere talen Guangxi Wuzhou Zhongheng Group Co.,Ltd

Aandelen

600252

CNE0000015F9

slotkoers Shanghai S.E. Andere beurzen 00:00:00 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,46 ^CNY	-0,81%		-1,60%	-1,99%

29/04	Guangxi Wuzhou Zhongheng Group Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
17/04	Guangxi Wuzhou Zhongheng Group Co.,Ltd (SHSE:600252) begint een aandeleninkoop voor CNY 200 miljoen aan haar aandelen, onder de machtiging goedgekeurd op 28 maart 2024.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.	17/04
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.	09/04
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	18/03
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test	10/11
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors	10/11
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index	18-09-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index	18-09-23
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug	15-09-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy	17-08-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	28-03-23
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended	24-01-23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28-10-22
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	26-08-22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index	20-06-22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index	13-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Guangxi Wuzhou Zhongheng Group Co.,Ltd

Aandelen

600252

CNE0000015F9

Andere talen

Filters